Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genentech CFO

Executive Summary

Genentech CFO Lou Lavigne will retire in March 2005 after serving as a Genentech finance exec for over 22 years. He first served as controller and was promoted to CFO in 1988. In his retirement, Lavigne intends to serve on the boards of other companies. Senior VP-Product Operations David Ebersman will replace Lavigne as CFO. Pat Yang, PhD, who serves as VP-South San Francisco manufacturing & engineering, will be promoted to senior VP-product operations. Yang joined the company from Merck in late 2003 (1"The Pink Sheet" Jan. 19, 2004, In Brief)...
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS044970

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel